Adhesive capsulitis of shoulder Musculoskeletal Diseases Adhesive capsulitis of shoulder
Conditions
Interventions
The control group (hyaluronate group) was injected only with hyaluronate (Hyal Shin Poong, PhD, Korea, 2.5-mL injection, 1% hyaluronan, molecular weight 940–1,020 kDa) five times in 1-week intervals.
Sponsors
Soonchunhyang University (South Korea)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who visited the Outpatient Clinic at Soonchunhyang University Hospital 2. Pain and limited movement of the shoulder joints
Exclusion criteria
Exclusion criteria: 1. Trauma 2. Stroke 3. Endocrine diseases 4. Arthritis in the shoulder 5. They had been administered an MAO (Monoamin monoamine oxidase) inhibitor during the past 2 weeks 6. They had hypersensitivity to opioids 7. They had received an intra-articular injection in the shoulder during the past 6 months 8. They had undergone other surgeries 9. They had been experiencing symptoms for more than 9 months 10. Ultrasonography showed a full-thickness tear in some tendons of the rotator cuff
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS), passive range of motion (PROM) of the shoulder joint, and Shoulder Pain and Disability Index (SPADI) scores were assessed at baseline and weeks 1, 2, 3, 4, and 6 after the initial injection. | — |
Countries
Korea, South
Outcome results
None listed